KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Operating Expenses (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Operating Expenses for 7 consecutive years, with $172.1 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 4.6% to $172.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $709.4 million through Dec 2025, down 2.36% year-over-year, with the annual reading at $709.4 million for FY2025, 2.36% down from the prior year.
  • Operating Expenses hit $172.1 million in Q4 2025 for GoodRx Holdings, down from $181.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $218.3 million in Q3 2023 to a low of $165.4 million in Q1 2021.
  • Historically, Operating Expenses has averaged $185.5 million across 5 years, with a median of $181.1 million in 2024.
  • Biggest YoY gain for Operating Expenses was 117.0% in 2021; the steepest drop was 55.52% in 2021.
  • Year by year, Operating Expenses stood at $201.5 million in 2021, then decreased by 9.49% to $182.4 million in 2022, then rose by 17.85% to $214.9 million in 2023, then dropped by 16.07% to $180.4 million in 2024, then fell by 4.6% to $172.1 million in 2025.
  • Business Quant data shows Operating Expenses for GDRX at $172.1 million in Q4 2025, $181.4 million in Q3 2025, and $176.3 million in Q2 2025.